<VariationArchive VariationID="5082" VariationName="NM_130837.3(OPA1):c.2873_2876del" VariationType="Deletion" Accession="VCV000005082" Version="56" RecordType="classified" NumberOfSubmissions="31" NumberOfSubmitters="29" DateLastUpdated="2024-07-29" DateCreated="2015-11-14" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20121" VariationID="5082">
      <GeneList>
        <Gene Symbol="OPA1" FullName="OPA1 mitochondrial dynamin like GTPase" GeneID="4976" HGNC_ID="HGNC:8140" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q29</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="193593208" stop="193697811" display_start="193593208" display_stop="193697811" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="193310932" stop="193415599" display_start="193310932" display_stop="193415599" Strand="+" />
          </Location>
          <OMIM>605290</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_130837.3(OPA1):c.2873_2876del</Name>
      <CanonicalSPDI>NC_000003.12:193667167:AGTTAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q29</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="193667168" stop="193667171" display_start="193667168" display_stop="193667171" variantLength="4" positionVCF="193667167" referenceAlleleVCF="CAGTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="193384957" stop="193384960" display_start="193384957" display_stop="193384960" variantLength="4" positionVCF="193384956" referenceAlleleVCF="CAGTT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>p.Val903Glyfs*3</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_337t2" sequenceAccession="LRG_337t2">
            <Expression>LRG_337t2:c.2873_2876del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130837.2" sequenceAccession="NM_130837" sequenceVersion="2" change="c.2873_2876del">
            <Expression>NM_130837.2:c.2873_2876del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130837.3" sequenceAccession="NM_130837" sequenceVersion="3" change="c.2873_2876del" MANESelect="true">
            <Expression>NM_130837.3:c.2873_2876del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130837.3" sequenceAccession="NM_130837" sequenceVersion="3" change="c.2873-2_2874del" MANESelect="true">
            <Expression>NM_130837.3:c.2873-2_2874del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.193384959_193384962del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.193384959_193384962del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.193667170_193667173del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.193667170_193667173del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011605.1" sequenceAccession="NG_011605" sequenceVersion="1" change="g.79027_79030del">
            <Expression>NG_011605.1:g.79027_79030del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015560.3" sequenceAccession="NM_015560" sequenceVersion="3" change="c.2708_2711delTTAG">
            <Expression>NM_015560.3:c.2708_2711delTTAG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_337" sequenceAccession="LRG_337">
            <Expression>LRG_337:g.79027_79030del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_337t1" sequenceAccession="LRG_337t1">
            <Expression>LRG_337t1:c.2708_2711del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA143822" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605290.0003" DB="OMIM" />
        <XRef Type="rs" ID="80356530" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND Autosomal dominant optic atrophy classic form" Accession="RCV000005387" Version="33">
        <ClassifiedConditionList TraitSetID="1406">
          <ClassifiedCondition DB="MedGen" ID="C0338508">Autosomal dominant optic atrophy classic form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-23" SubmissionCount="11">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND not provided" Accession="RCV000081763" Version="50">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-26" SubmissionCount="11">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND Abortive cerebellar ataxia" Accession="RCV000210745" Version="9">
        <ClassifiedConditionList TraitSetID="26392">
          <ClassifiedCondition DB="MedGen" ID="C0221061">Abortive cerebellar ataxia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND Mitochondrial disease" Accession="RCV000508703" Version="9">
        <ClassifiedConditionList TraitSetID="7949">
          <ClassifiedCondition DB="MedGen" ID="C0751651">Mitochondrial disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND Retinal dystrophy" Accession="RCV001073751" Version="10">
        <ClassifiedConditionList TraitSetID="12366">
          <ClassifiedCondition DB="MedGen" ID="C0854723">Retinal dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy" Accession="RCV001542739" Version="10">
        <ClassifiedConditionList TraitSetID="6291">
          <ClassifiedCondition DB="MedGen" ID="C3276549">Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND multiple conditions" Accession="RCV002490322" Version="8">
        <ClassifiedConditionList TraitSetID="31956">
          <ClassifiedCondition DB="MedGen" ID="C0221061">Abortive cerebellar ataxia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0338508">Autosomal dominant optic atrophy classic form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1847730">Glaucoma, normal tension, susceptibility to</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4225163">Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3276549">Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND Tip-toe gait" Accession="RCV003319160" Version="9">
        <ClassifiedConditionList TraitSetID="45469">
          <ClassifiedCondition DB="MedGen" ID="C0427144">Tip-toe gait</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-11-23" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND OPA1-related disorder" Accession="RCV004532291" Version="3">
        <ClassifiedConditionList TraitSetID="74782">
          <ClassifiedCondition>OPA1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_130837.3(OPA1):c.2873_2876del AND See cases" Accession="RCV004584316" Version="1">
        <ClassifiedConditionList TraitSetID="16994">
          <ClassifiedCondition>See cases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-18" NumberOfSubmissions="31" NumberOfSubmitters="29" DateCreated="2015-11-14" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11017079</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11440988</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11440989</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11810270</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12036970</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14961560</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15505825</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16513463</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17306754</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18222991</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20157015</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20417570</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20659957</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20952381</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21636302</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21646330</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22042570</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22857269</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23250881</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23401657</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24907432</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25012220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25641387</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26385429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28812649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32025183</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33546218</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33884488</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34242285</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">37091313</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9490303</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9917792</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OPA1</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301426</ID>
          <ID Source="BookShelf">NBK1248</ID>
        </Citation>
        <DescriptionHistory Dated="2021-03-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1406" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Optic atrophy, juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kjer-type optic atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant optic atrophy classic form</ElementValue>
                <XRef ID="717336005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic Atrophy Type 1</ElementValue>
                <XRef ID="NBK1248" DB="GeneReviews" />
                <XRef ID="Optic+atrophy+1/5380" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPA1</ElementValue>
                <XRef Type="MIM" ID="165500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">OAK</ElementValue>
                <XRef Type="MIM" ID="165500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Optic atrophy type 1 (OPA1, or Kjer type optic atrophy) is characterized by bilateral and symmetric optic nerve pallor associated with insidious decrease in visual acuity (usually between ages 4 and 6 years), visual field defects, and color vision defects. Visual impairment is usually moderate (6/10 to 2/10), but ranges from mild or even insignificant to severe (legal blindness with acuity &lt;1/20). The visual field defect is typically centrocecal, central, or paracentral; it is often large in those with severe disease. The color vision defect is often described as acquired blue-yellow loss (tritanopia). Other findings can include auditory neuropathy resulting in sensorineural hearing loss that ranges from severe and congenital to subclinical (i.e., identified by specific audiologic testing only). Visual evoked potentials are typically absent or delayed; pattern electroretinogram shows an abnormal N95:P50 ratio. Tritanopia is the classic feature of color vision defect, but more diffuse nonspecific dyschromatopsia is not uncommon. Ophthalmoscopic examination discloses temporal or diffuse pallor of the optic discs, sometimes associated with optic disc excavation. The neuroretinal rim shows some pallor in most cases, sometimes associated with a temporal pigmentary gray crescent.</Attribute>
                <XRef ID="NBK1248" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9890" />
                <XRef ID="9890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98673" DB="Orphanet" />
              <XRef ID="C0338508" DB="MedGen" />
              <XRef ID="MONDO:0008134" DB="MONDO" />
              <XRef Type="MIM" ID="165500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16994" Type="PhenotypeInstruction" ContributesToAggregateClassification="true">
            <Trait ID="18728" Type="PhenotypeInstruction">
              <Name>
                <ElementValue Type="Preferred">See cases</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="74782" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="62430" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">OPA1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPA1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPA1 related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="45469" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="32388" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Tip-toe gait</ElementValue>
                <XRef ID="HP:0030051" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Toe walking</ElementValue>
                <XRef ID="HP:0040083" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0427144" DB="MedGen" />
              <XRef Type="primary" ID="HP:0030051" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002394" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0040083" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31956" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3314" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy</ElementValue>
                <XRef ID="MONDO:0007429" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15057" />
                <XRef ID="15057" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3276549" DB="MedGen" />
              <XRef ID="MONDO:0007429" DB="MONDO" />
              <XRef Type="MIM" ID="125250" DB="OMIM" />
            </Trait>
            <Trait ID="1925" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLAUCOMA, NORMAL PRESSURE, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="MIM" ID="606657" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glaucoma, normal tension, susceptibility to</ElementValue>
                <XRef ID="Glaucoma%2C+normal+tension%2C+susceptibility+to/8467" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011693" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OPA1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NTG</ElementValue>
                <XRef Type="MIM" ID="606657" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPG</ElementValue>
                <XRef Type="MIM" ID="606657" DB="OMIM" />
              </Symbol>
              <XRef ID="C1847730" DB="MedGen" />
              <XRef ID="MONDO:0011693" DB="MONDO" />
              <XRef Type="MIM" ID="606657" DB="OMIM" />
            </Trait>
            <Trait ID="591" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OPTIC ATROPHY, INFANTILE HEREDITARY, WITH NEUROLOGIC ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="210000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy, infantile hereditary, Behr complicated form of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy in early childhood, associated with ataxia, spasticity, mental retardation, and posterior column sensory loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Behr syndrome</ElementValue>
                <XRef ID="MONDO:0008858" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Abortive cerebellar ataxia</ElementValue>
                <XRef ID="66988006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BEHRS</ElementValue>
                <XRef Type="MIM" ID="210000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="849" />
                <XRef ID="849" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517884</ID>
                <ID Source="BookShelf">NBK487393</ID>
              </Citation>
              <XRef ID="1239" DB="Orphanet" />
              <XRef ID="C0221061" DB="MedGen" />
              <XRef ID="MONDO:0008858" DB="MONDO" />
              <XRef Type="MIM" ID="210000" DB="OMIM" />
            </Trait>
            <Trait ID="35259" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)</ElementValue>
                <XRef ID="MONDO:0014820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OPA1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MTDPS14</ElementValue>
                <XRef Type="MIM" ID="616896" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517884</ID>
                <ID Source="BookShelf">NBK487393</ID>
              </Citation>
              <XRef ID="C4225163" DB="MedGen" />
              <XRef ID="MONDO:0014820" DB="MONDO" />
              <XRef Type="MIM" ID="616896" DB="OMIM" />
            </Trait>
            <Trait ID="5679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Optic atrophy, juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kjer-type optic atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant optic atrophy classic form</ElementValue>
                <XRef ID="717336005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic Atrophy Type 1</ElementValue>
                <XRef ID="NBK1248" DB="GeneReviews" />
                <XRef ID="Optic+atrophy+1/5380" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPA1</ElementValue>
                <XRef Type="MIM" ID="165500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">OAK</ElementValue>
                <XRef Type="MIM" ID="165500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Optic atrophy type 1 (OPA1, or Kjer type optic atrophy) is characterized by bilateral and symmetric optic nerve pallor associated with insidious decrease in visual acuity (usually between ages 4 and 6 years), visual field defects, and color vision defects. Visual impairment is usually moderate (6/10 to 2/10), but ranges from mild or even insignificant to severe (legal blindness with acuity &lt;1/20). The visual field defect is typically centrocecal, central, or paracentral; it is often large in those with severe disease. The color vision defect is often described as acquired blue-yellow loss (tritanopia). Other findings can include auditory neuropathy resulting in sensorineural hearing loss that ranges from severe and congenital to subclinical (i.e., identified by specific audiologic testing only). Visual evoked potentials are typically absent or delayed; pattern electroretinogram shows an abnormal N95:P50 ratio. Tritanopia is the classic feature of color vision defect, but more diffuse nonspecific dyschromatopsia is not uncommon. Ophthalmoscopic examination discloses temporal or diffuse pallor of the optic discs, sometimes associated with optic disc excavation. The neuroretinal rim shows some pallor in most cases, sometimes associated with a temporal pigmentary gray crescent.</Attribute>
                <XRef ID="NBK1248" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9890" />
                <XRef ID="9890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98673" DB="Orphanet" />
              <XRef ID="C0338508" DB="MedGen" />
              <XRef ID="MONDO:0008134" DB="MONDO" />
              <XRef Type="MIM" ID="165500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="26392" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="591" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OPTIC ATROPHY, INFANTILE HEREDITARY, WITH NEUROLOGIC ABNORMALITIES</ElementValue>
                <XRef Type="MIM" ID="210000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy, infantile hereditary, Behr complicated form of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Optic atrophy in early childhood, associated with ataxia, spasticity, mental retardation, and posterior column sensory loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Behr syndrome</ElementValue>
                <XRef ID="MONDO:0008858" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Abortive cerebellar ataxia</ElementValue>
                <XRef ID="66988006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BEHRS</ElementValue>
                <XRef Type="MIM" ID="210000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="849" />
                <XRef ID="849" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517884</ID>
                <ID Source="BookShelf">NBK487393</ID>
              </Citation>
              <XRef ID="1239" DB="Orphanet" />
              <XRef ID="C0221061" DB="MedGen" />
              <XRef ID="MONDO:0008858" DB="MONDO" />
              <XRef Type="MIM" ID="210000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12366" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18440" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinal dystrophy</ElementValue>
                <XRef ID="HP:0000556" DB="Human Phenotype Ontology" />
                <XRef ID="314407005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inherited retinal dystrophy</ElementValue>
                <XRef ID="MONDO:0019118" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18916" />
                <XRef ID="18916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="71862" DB="Orphanet" />
              <XRef ID="C0854723" DB="MedGen" />
              <XRef ID="D058499" DB="MeSH" />
              <XRef ID="MONDO:0019118" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000556" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007736" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007910" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007974" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007982" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7949" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9530" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial disease</ElementValue>
                <XRef ID="MONDO:0044970" DB="MONDO" />
                <XRef ID="68380" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial diseases</ElementValue>
                <XRef ID="Mitochondrial+Disorders/4830" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial disorder</ElementValue>
              </Name>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301403</ID>
                <ID Source="BookShelf">NBK1224</ID>
              </Citation>
              <Citation Type="general" Abbrev="MMS, 2014">
                <ID Source="PubMed">25503498</ID>
              </Citation>
              <Citation Type="general" Abbrev="MMS, 2017">
                <ID Source="PubMed">28749475</ID>
                <ID Source="pmc">7804217</ID>
              </Citation>
              <XRef ID="68380" DB="Orphanet" />
              <XRef ID="C0751651" DB="MedGen" />
              <XRef ID="D028361" DB="MeSH" />
              <XRef ID="MONDO:0044970" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6291" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3314" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy</ElementValue>
                <XRef ID="MONDO:0007429" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15057" />
                <XRef ID="15057" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3276549" DB="MedGen" />
              <XRef ID="MONDO:0007429" DB="MONDO" />
              <XRef Type="MIM" ID="125250" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="500015" SubmissionDate="2016-04-07" DateLastUpdated="2016-04-09" DateCreated="2016-04-09">
        <ClinVarSubmissionID localKey="605290.0003_BEHR SYNDROME" title="OPA1, 4-BP DEL, 2708TTAG_BEHR SYNDROME" />
        <ClinVarAccession Accession="SCV000266834" DateUpdated="2016-04-09" DateCreated="2016-04-09" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 families, Delettre et al. (2000) found that members with autosomal dominant optic atrophy (165500) had a 4-bp deletion in exon 27 of the OPA1 gene, 2708delTTAG, that caused 2 amino acid substitutions (val903 to gly, arg904 to asp) and a premature stop at codon 905. This mutation was present in an asymptomatic carrier in one family but was fully penetrant in the other 2 families. This penetrance was expected since minimally affected patients and asymptomatic carriers (with no detectable optic atrophy on fundus examination) had been described. The 3 families were apparently unrelated, but all originated from the northern French provinces and Belgium. Founder effect had been demonstrated by haplotype studies in the British Isles (Votruba et al., 1998; Johnston et al., 1999).</Attribute>
              <Citation>
                <ID Source="PubMed">11017079</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9490303</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9917792</ID>
              </Citation>
              <XRef DB="OMIM" ID="165500" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Toomes et al. (2001) haplotyped 8 unrelated individuals with the 2708delTTAG mutation and concluded that this may be a mutation hotspot and not an ancient mutation, thus excluding a major founder effect at the OPA1 locus. A recalculation of the penetrance of this disorder within 2 of 8 families indicated figures as low as 43% and 62% associated with the 2708delTTAG mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">11440989</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs with clinical features of Behr syndrome (BEHRS; 210000), Schaaf et al. (2011) identified compound heterozygosity for 2 mutations in the OPA1 gene: 2708delTTAG and I382M (605290.0018). Each parent was heterozygous for 1 of the mutations. The father, who carried the truncating mutation, had mild optic atrophy and bilateral sensorineural hearing loss, whereas the mother, who carried the missense mutation, had myopia, with no evidence of optic atrophy, and mild sensorineural hearing loss. Schaaf et al. (2011) considered the more severe phenotype in the children to be consistent with semidominant inheritance.</Attribute>
              <Citation>
                <ID Source="PubMed">21636302</ID>
              </Citation>
              <XRef DB="OMIM" ID="210000" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old girl with Behr syndrome, Bonneau et al. (2014) identified compound heterozygous mutations in the OPA1 gene: a 4-bp deletion (c.2708_2711) in exon 27, resulting in a frameshift and premature termination (Val903GlyfsTer), and a c.1204G-A transition in exon 12, resulting in a val402-to-met (V402M; 605290.0021) substitution.</Attribute>
              <Citation>
                <ID Source="PubMed">25012220</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <Name>OPA1, 4-BP DEL, 2708TTAG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 2708TTAG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605290.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BEHR SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25567" SubmissionDate="2016-04-07" DateLastUpdated="2016-04-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605290.0003_OPTIC ATROPHY 1" title="OPA1, 4-BP DEL, 2708TTAG_OPTIC ATROPHY 1" />
        <ClinVarAccession Accession="SCV000025567" DateUpdated="2016-04-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 families, Delettre et al. (2000) found that members with autosomal dominant optic atrophy (165500) had a 4-bp deletion in exon 27 of the OPA1 gene, 2708delTTAG, that caused 2 amino acid substitutions (val903 to gly, arg904 to asp) and a premature stop at codon 905. This mutation was present in an asymptomatic carrier in one family but was fully penetrant in the other 2 families. This penetrance was expected since minimally affected patients and asymptomatic carriers (with no detectable optic atrophy on fundus examination) had been described. The 3 families were apparently unrelated, but all originated from the northern French provinces and Belgium. Founder effect had been demonstrated by haplotype studies in the British Isles (Votruba et al., 1998; Johnston et al., 1999).</Attribute>
              <Citation>
                <ID Source="PubMed">11017079</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9490303</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9917792</ID>
              </Citation>
              <XRef DB="OMIM" ID="165500" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Toomes et al. (2001) haplotyped 8 unrelated individuals with the 2708delTTAG mutation and concluded that this may be a mutation hotspot and not an ancient mutation, thus excluding a major founder effect at the OPA1 locus. A recalculation of the penetrance of this disorder within 2 of 8 families indicated figures as low as 43% and 62% associated with the 2708delTTAG mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">11440989</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs with clinical features of Behr syndrome (BEHRS; 210000), Schaaf et al. (2011) identified compound heterozygosity for 2 mutations in the OPA1 gene: 2708delTTAG and I382M (605290.0018). Each parent was heterozygous for 1 of the mutations. The father, who carried the truncating mutation, had mild optic atrophy and bilateral sensorineural hearing loss, whereas the mother, who carried the missense mutation, had myopia, with no evidence of optic atrophy, and mild sensorineural hearing loss. Schaaf et al. (2011) considered the more severe phenotype in the children to be consistent with semidominant inheritance.</Attribute>
              <Citation>
                <ID Source="PubMed">21636302</ID>
              </Citation>
              <XRef DB="OMIM" ID="210000" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old girl with Behr syndrome, Bonneau et al. (2014) identified compound heterozygous mutations in the OPA1 gene: a 4-bp deletion (c.2708_2711) in exon 27, resulting in a frameshift and premature termination (Val903GlyfsTer), and a c.1204G-A transition in exon 12, resulting in a val402-to-met (V402M; 605290.0021) substitution.</Attribute>
              <Citation>
                <ID Source="PubMed">25012220</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <Name>OPA1, 4-BP DEL, 2708TTAG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 2708TTAG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605290.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OPTIC ATROPHY 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2856908" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:487" />
        <ClinVarAccession Accession="SCV001446520" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Unknown mechanism</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX183469</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000648" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001138" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CAGTT" start="193384956" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2993454" SubmissionDate="2021-03-14" DateLastUpdated="2021-09-19" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="NM_130837.2:c.2873_2876delTTAG|OMIM:165500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001519161" DateUpdated="2021-09-19" DateCreated="2021-09-19" Type="SCV" Version="1" SubmitterName="Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione Stella Maris" OrgID="507178" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.2:c.2873_2876delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9291375</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3878410" SubmissionDate="2021-10-04" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_015560.2:c.2708_2711delTTAG|OMIM:165500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984459" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-18">
          <ReviewStatus>flagged submission</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>The p.Val903fs variant in the OPA1 gene was previously reported in the heterozygous state in several individuals with optic atrophy (PMID: 11017079 11440989) though penetrance was incomplete ranging between 43% and 62% (PMID: 11440989). In addition this variant was also identified in the heterozygous state in another patient with optic atrophy plus spastic paraplegia Duane retraction syndrome migraine with atypical aura patent foramen ovale and muscle fibre abnormalities. However this patient's father and sister were unaffected carriers of the same variants again suggesting incomplete penetrance (PMID: 21646330). A mouse model carrying this variant displayed multi-systemic poly-degenerative phenotype with a presentation associating signs of visual failure deafness encephalomyopathy peripheral neuropathy ataxia and cardiomyopathy (PMID: 23250881). The Val903fs variant was also identified in 10/282600 (0.0035% 0 homozygotes) total alleles in the Genome Aggregation Database (gnomAD). This frameshift variant is predicted to alter the protein's amino acid sequence beginning at position 903 and lead to a premature termination codon 3 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In summary this variant meets our criteria for pathogenicity for dominant optic atrophy with reduced penetrance.</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Reason: This record appears to be redundant with a more recent record from the same submitter.</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Notes: SCV001984459 appears to be redundant with SCV002818199.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB10465084</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4538669" SubmissionDate="2022-03-25" DateLastUpdated="2022-04-02" DateCreated="2022-04-02">
        <ClinVarSubmissionID localKey="3-193384956-CAGTT-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002318897" DateUpdated="2022-04-02" DateCreated="2022-04-02" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14961560</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20417570</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11017079</ID>
          </Citation>
          <Comment>Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been observed in multiple (&gt;3) similarly affected unrelated individuals (PMID: 20417570, 14961560). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000729" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008499" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001270" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.3:c.2873_2876del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11208158</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5041270" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_130837.3:c.2873-2_2874del|OMIM:165500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579707" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="80356530" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.3:c.2873-2_2874del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS4, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1359162" SubmissionDate="2017-11-15" DateLastUpdated="2022-12-11" DateCreated="2017-10-14">
        <ClinVarSubmissionID localKey="19_October 2017|OMIM:165500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693465" DateUpdated="2022-12-11" DateCreated="2017-10-14" Type="SCV" Version="2" SubmitterName="Center of Genomic medicine, Geneva, University Hospital of Geneva" OrgID="505593" OrganizationCategory="laboratory" OrgAbbreviation="GenMed_GVA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshift variant (deletion of four nucleotides) in the OPA1 gene was identified in a male young patient and also his mother, both diagnosed with optic atrophy 1.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Val903Glyfs*3)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Genome_Clinic_of_Geneva_November2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5431620" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_015560.2:c.2708_2711del|OMIM:125250;165500;210000;606657;616896" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002777553" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="125250" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="210000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606657" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616896" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5502682" SubmissionDate="2022-12-17" DateLastUpdated="2023-01-07" DateCreated="2023-01-07">
        <ClinVarSubmissionID localKey="NM_015560.2:c.2708_2711del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002818199" DateUpdated="2023-01-07" DateCreated="2023-01-07" Type="SCV" Version="1" SubmitterName="Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12445851</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7697279" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="295225|OPA1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004120905" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The OPA1 c.2873_2876delTTAG variant is predicted to result in a frameshift and premature protein termination (p.Val958Glyfs*3). This variant is also often denoted as c.2708_2711delTTAG (p.Val903Glyfs*3) in the alternate transcript NM_015560.2. This variant has been reported many times as causative for autosomal dominant optic atrophy (see for examples Delettre et al. 2000. PubMed ID: 11017079; Pretegiani et al. 2011. PubMed ID: 21646330; Gaier et al. 2017. PubMed ID: 28848318; Lin et al. 2021. PubMed ID: 34573359). This variant has also been reported in the compound heterozygous state in an individual with early-onset Behr syndrome and the unaffected mother was a carrier of this variant, suggesting there may be incomplete penetrance (Bonneau et al. 2014. PubMed ID: 25012220). This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-193384956-CAGTT-C). Frameshift variants in OPA1 are expected to be pathogenic, and this variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/5082). Given all the evidence, we interpret c.2873_2876del (p.Val958Glyfs*3) as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.2:c.2873_2876delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OPA1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7895276" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1555992|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004226069" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11017079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23250881</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32025183</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33884488</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34242285</ID>
          </Citation>
          <Comment>PP1, PS4, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_015560.2:exon 27</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Val903Glyfs*3</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7131577" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="66c2307a788c8f2243dc5e280d274030e9dbeede4aa4eeceed9fd4d7626441d2|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003824243" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3117415" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4848387|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001591733" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11440988</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20157015</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20952381</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25012220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11017079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26385429</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val903Glyfs*3) in the OPA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OPA1 are known to be pathogenic (PMID: 11440988, 20157015, 20952381, 25012220). This variant is present in population databases (rs745560444, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with dominant optic atrophy (PMID: 11017079, 26385429). It has also been observed to segregate with disease in related individuals. This variant is also known as c.2708delTTAG and c.2873_2876delTTAG (p.V958Gfs*3). ClinVar contains an entry for this variant (Variation ID: 5082). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.193384957_193384960del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9830641" SubmissionDate="2024-06-29" DateLastUpdated="2024-07-07" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_015560.3:c.2708_2711delTTAG|OPA1-Related Disorders" />
        <ClinVarAccession Accession="SCV005061372" DateUpdated="2024-07-07" DateCreated="2024-06-17" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17306754</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18222991</ID>
          </Citation>
          <Comment>Variant summary: OPA1 c.2708_2711delTTAG (p.Val903GlyfsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a 3' acceptor site. Three predict the variant creates a cryptic 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 3.2e-05 in 251242 control chromosomes (gnomAD). c.2708_2711delTTAG has been reported in the literature in multiple individuals affected with autosomal dominant optic atrophy (Cohn_2008). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and this variant showed it was more prone to cell death than controls after an exogenous oxidative stress in fibroblasts (Zanna_2008). The following publications have been ascertained in the context of this evaluation (PMID: 17306754, 18222991). ClinVar contains an entry for this variant (Variation ID: 5082). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.3:c.2708_2711delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OPA1-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-03.anno.csv</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5039439" SubmissionDate="2024-06-28" DateLastUpdated="2024-07-07" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="306131483|see cases" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002577870" DateUpdated="2024-07-07" DateCreated="2022-10-08" Type="SCV" Version="2" SubmitterName="Institute of Human Genetics, University Hospital Muenster" OrgID="507439" OrganizationCategory="clinic" OrgAbbreviation="IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG categories: PVS1,PP1,PP4,PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>NextSeq 500</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001093" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CAGTT" start="193384956" stop="193384960" variantLength="5" />
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="80356530" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="PhenotypeInstruction">
          <Trait Type="PhenotypeInstruction">
            <Name>
              <ElementValue Type="Preferred">see cases</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12122793</SubmissionName>
          <SubmissionName>SUB14571546</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1122691" SubmissionDate="2017-04-07" DateLastUpdated="2017-05-22" DateCreated="2017-05-22">
        <ClinVarSubmissionID localKey="NM_015560.2:c.2708_2711delTTAG|MedGen:C0751651" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000575923" DateUpdated="2017-05-22" DateCreated="2017-05-22" Type="SCV" Version="1" SubmitterName="Wellcome Centre for Mitochondrial Research, Newcastle University" OrgID="504862" OrganizationCategory="laboratory" OrgAbbreviation="WCMR" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">28812649</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751651" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28812649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28812649</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB2568183</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="416784" SubmissionDate="2017-06-30" DateLastUpdated="2019-07-31" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="1664_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000228466" DateUpdated="2019-07-31" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000113698" DateChanged="2018-02-14" Version="3" />
        </ReplacedList>
        <Classification DateLastEvaluated="2017-01-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation>
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="23" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="23" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="-" referenceAllele="TTAG" start="193384959" stop="193384962" variantLength="4" />
            <GeneLocation>NM_015560.2:Ex27</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD002708" />
            <XRef DB="dbSNP" ID="80356530" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OPA1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2442630" SubmissionDate="2019-10-15" DateLastUpdated="2020-04-18" DateCreated="2020-04-18">
        <ClinVarSubmissionID localKey="NM_015560.2:c.2708_2711delTTAG|Retinal dystrophy" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001239311" DateUpdated="2020-04-18" DateCreated="2020-04-18" Type="SCV" Version="1" SubmitterName="Blueprint Genetics" OrgID="500188" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Blueprint Genetics Variant Classification Scheme</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8okxtmpf/blueprint_genetics_variant_classification_scheme.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Retinal dystrophy</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>My Retina Tracker patient</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB6252865</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3047510" SubmissionDate="2021-03-19" DateLastUpdated="2021-03-28" DateCreated="2021-03-28">
        <ClinVarSubmissionID localKey="NM_130837.2:c.2873_2876del|OMIM:165500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001548160" DateUpdated="2021-03-28" DateCreated="2021-03-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Molecular Genetics, University of Zurich" OrgID="300471" OrganizationCategory="laboratory" OrgAbbreviation="Medmolgen" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33546218</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NextSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Citation>
                <ID Source="PubMed">33546218</ID>
              </Citation>
              <Description>WES</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">WES</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.2:c.2873_2876del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">33546218</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB9315178</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3463518" SubmissionDate="2021-07-15" DateLastUpdated="2021-07-27" DateCreated="2021-07-27">
        <ClinVarSubmissionID localKey="NC_000003.11:g.193384959_193384962del|OMIM:125250" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001760119" DateUpdated="2021-07-27" DateCreated="2021-07-27" Type="SCV" Version="1" SubmitterName="Genomics England Pilot Project, Genomics England" OrgID="508170" OrganizationCategory="laboratory" OrgAbbreviation="GeL_Pilot" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACGS Guidelines, 2016</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ylgat5th/acgs_best_practice_guidelines_for_variant_classification_in_rare_disease_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.193384959_193384962del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="125250" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10010620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3778002" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey=":Chr.3_193384956_193384960_CAGTT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001921462" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Clinical Genetics, Academic Medical Center" OrgID="319965" OrganizationCategory="laboratory" OrgAbbreviation="KG-DNA AMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CAGTT" start="193384956" stop="193384960" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10399984</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="467107" SubmissionDate="2021-09-24" DateLastUpdated="2019-04-17" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="GDXSV:151709" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000252013" DateUpdated="2019-04-17" DateCreated="2015-10-11" Type="SCV" Version="10" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>An Opa1 mouse model carrying the c.2708_2711delTTAG variant displayed a multi-systemic poly-degenerative phenotype including signs of visual failure, deafness, encephalomyopathy, peripheral neuropathy, ataxia, cardiomyopathy, and premature age-related axonal and myelin degenerations (Sarzi et al., 2012); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23665194, 25012220, 26031781, 21646330, 25699009, 26385429, 27260406, 25564500, 23250881, 27974645, 11017079, 28848318, 15505825, 20952381, 11440989, 32025183, 31500643, 31589614, 33300680)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:45948</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3864653" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-08" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey=":Chr.3_193384956_193384960_CAGTT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001974149" DateUpdated="2021-10-08" DateCreated="2021-10-08" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CAGTT" start="193384956" stop="193384960" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1174109" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2017-10-14">
        <ClinVarSubmissionID localKey="genomeconnect_20489_15054" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000606947" DateUpdated="2022-02-13" DateCreated="2017-10-14" Type="SCV" Version="2" SubmitterName="GenomeConnect, ClinGen" OrgID="506185" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant was identified in multiple participants. Variant interpreted as Pathogenic and reported, most recently, on 11-07-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <TypePlatform>Gene Panel Sequencing</TypePlatform>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2019-11-07" integerValue="26957">GeneDx</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">genomeconnect_20489_622</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2020-03-27" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000517" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000504" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000540" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000587" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000365" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000360" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">40</Age>
              <Age Type="maximum" age_unit="years">49</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <TypePlatform>Gene Panel Sequencing</TypePlatform>
              <Purpose>validation</Purpose>
              <Description>Sanger Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2016-02-03" integerValue="26957">GeneDx</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">genomeconnect_15054</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2021-04-05" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002686" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000496" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000504" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000587" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001290" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000739" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000716" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000722" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007565" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0410009" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003011" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002577" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002242" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000479" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002579" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GenomeConnect_hg19_81817</SubmissionName>
          <SubmissionName>SUB11035566</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41284" SubmissionDate="2015-11-13" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_015560.2:c.2708_2711delTTAG|OMIM:165500" />
        <ClinVarAccession Accession="SCV000041284" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11440989</ID>
          </Citation>
          <Citation>
            <ID Source="BookShelf">NBK1248</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_056375.2:p.Val903GlyfsTer3</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711delTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0338508" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7543925" SubmissionDate="2023-09-04" DateLastUpdated="2023-09-09" DateCreated="2023-09-09">
        <ClinVarSubmissionID localKey="4093778_NM_130837.3:c.2873_2876del|OMIM:165500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004032248" DateUpdated="2023-09-09" DateCreated="2023-09-09" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria applied: PVS1,PS4,PS3_MOD</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000648" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.3:c.2873_2876del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13814879</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569492" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="168-20230924" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004045808" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0000648" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CAGTT" start="193384956" stop="193384960" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="165500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-09-24</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1198038" SubmissionDate="2024-01-03" DateLastUpdated="2024-01-26" DateCreated="2016-10-09">
        <ClinVarSubmissionID localKey="A100|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000614384" DateUpdated="2024-01-26" DateCreated="2016-10-09" Type="SCV" Version="4" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25012220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25641387</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24907432</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20157015</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11810270</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11440989</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12036970</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18222991</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11017079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21646330</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23250881</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11440988</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16513463</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22857269</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14961560</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15505825</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21636302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22042570</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20952381</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23401657</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20659957</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. This variant is one of the most common pathogenic variants associated with autosomal dominant optic atrophy (ADOA; PMID: 11440989, 22857269), and therefore the frequency of this variant in the general population is consistent with pathogenicity (Genome Aggregation Database (gnomAD), Cambridge, MA (URL: http://gnomad.broadinstitute.org)). This variant has been reported to exhibit reduced penetrance (PMID: 11440989). Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 18222991) This variant occurs with an alternate explanation for disease significantly less often than expected, suggesting this variant may be associated with disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015560.2:c.2708_2711del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
          <SubmissionName>SUB14108777</SubmissionName>
          <SubmissionName>SUB4481681</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7527458" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-23" DateCreated="2023-08-05">
        <ClinVarSubmissionID localKey="OPA1 c.2873_2876del" submittedAssembly="hg38" title="OPA1 c.2873_2876del" />
        <ClinVarAccession Accession="SCV004023198" DateUpdated="2024-06-23" DateCreated="2023-08-05" Type="SCV" Version="2" SubmitterName="Practice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino" OrgID="507943" OrganizationCategory="consortium" OrgAbbreviation="Praxis Pomarino" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">37091313</ID>
          </Citation>
          <Comment>Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Thermo Fisher S5</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>Gene panel analysis</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000256" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003202" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003307" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001761" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001156" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000767" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">limited range of motion of upper ankle</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1">
              <Name>OPA1 mitochondrial dynamin like GTPase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="rs80356530" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130837.2:c.2873_2876del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0427144" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>OPA1 c.2873_2876del</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2468079" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="100887|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001246487" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CAGTT" start="193384956" stop="193384960" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003307" MappingRef="HP">
        <MedGen CUI="C0024003" Name="Hyperlordosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001290" MappingRef="HP">
        <MedGen CUI="C1858120" Name="Generalized hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2468079" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5039439" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001093" MappingRef="HP">
        <MedGen CUI="C2676026" Name="Optic nerve dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000545" MappingRef="HP">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431620" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5039439" TraitType="PhenotypeInstruction" MappingType="Name" MappingValue="see cases" MappingRef="Preferred">
        <MedGen CUI="None" Name="See cases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431620" TraitType="Disease" MappingType="XRef" MappingValue="125250" MappingRef="OMIM">
        <MedGen CUI="C3276549" Name="Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2856908" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001138" MappingRef="HP">
        <MedGen CUI="C3887709" Name="Optic neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7697279" TraitType="Disease" MappingType="Name" MappingValue="OPA1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="OPA1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538669" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001270" MappingRef="HP">
        <MedGen CUI="C1854301" Name="Motor delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3778002" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001761" MappingRef="HP">
        <MedGen CUI="C0728829" Name="Pes cavus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000504" MappingRef="HP">
        <MedGen CUI="C4025846" Name="Abnormality of vision" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1198038" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569492" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0410009" MappingRef="HP">
        <MedGen CUI="C4073188" Name="Abnormality of the somatic nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2856908" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000587" MappingRef="HP">
        <MedGen CUI="C0029131" Name="Abnormal optic nerve morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3463518" TraitType="Disease" MappingType="XRef" MappingValue="125250" MappingRef="OMIM">
        <MedGen CUI="C3276549" Name="Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002579" MappingRef="HP">
        <MedGen CUI="C1836923" Name="Gastrointestinal dysmotility" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538669" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002250" MappingRef="HP">
        <MedGen CUI="C4025715" Name="Abnormal large intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7895276" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000722" MappingRef="HP">
        <MedGen CUI="C0600104" Name="Compulsive behaviors" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431620" TraitType="Disease" MappingType="XRef" MappingValue="606657" MappingRef="OMIM">
        <MedGen CUI="C1847730" Name="Glaucoma, normal tension, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538669" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="500015" TraitType="Disease" MappingType="Name" MappingValue="BEHR SYNDROME" MappingRef="Alternate">
        <MedGen CUI="C0221061" Name="Abortive cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000365" MappingRef="HP">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7543925" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7131577" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3878410" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2442630" TraitType="Disease" MappingType="Name" MappingValue="Retinal dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0854723" Name="Retinal dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000545" MappingRef="HP">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000479" MappingRef="HP">
        <MedGen CUI="C0035300" Name="Abnormal retinal morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003011" MappingRef="HP">
        <MedGen CUI="C4021745" Name="Abnormality of the musculature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569492" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25567" TraitType="Disease" MappingType="Name" MappingValue="OPTIC ATROPHY 1" MappingRef="Preferred">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538669" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000729" MappingRef="HP">
        <MedGen CUI="C0856975" Name="Autistic behavior" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002686" MappingRef="HP">
        <MedGen CUI="C0032967" Name="Pregnancy history" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000496" MappingRef="HP">
        <MedGen CUI="C0497202" Name="Abnormality of eye movement" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="416784" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5041270" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Disease" MappingType="XRef" MappingValue="C0427144" MappingRef="MedGen">
        <MedGen CUI="C0427144" Name="Tip-toe gait" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000716" MappingRef="HP">
        <MedGen CUI="C0011581" Name="Depression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000256" MappingRef="HP">
        <MedGen CUI="C2243051" Name="Macrocephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431620" TraitType="Disease" MappingType="XRef" MappingValue="616896" MappingRef="OMIM">
        <MedGen CUI="C4225163" Name="Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="467107" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000587" MappingRef="HP">
        <MedGen CUI="C0029131" Name="Abnormal optic nerve morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7543925" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000648" MappingRef="HP">
        <MedGen CUI="C0029124" Name="Optic atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000767" MappingRef="HP">
        <MedGen CUI="C2051831" Name="Pectus excavatum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2993454" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002242" MappingRef="HP">
        <MedGen CUI="C4316788" Name="Abnormal intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431620" TraitType="Disease" MappingType="XRef" MappingValue="210000" MappingRef="OMIM">
        <MedGen CUI="C0221061" Name="Abortive cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569492" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000648" MappingRef="HP">
        <MedGen CUI="C0029124" Name="Optic atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3117415" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3047510" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000517" MappingRef="HP">
        <MedGen CUI="C0549651" Name="Abnormal lens morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000360" MappingRef="HP">
        <MedGen CUI="C0040264" Name="Tinnitus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002577" MappingRef="HP">
        <MedGen CUI="C4025699" Name="Abnormal stomach morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007565" MappingRef="HP">
        <MedGen CUI="C1861975" Name="Cafe au lait spots, multiple" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9830641" TraitType="Disease" MappingType="Name" MappingValue="OPA1-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="OPA1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2856908" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000648" MappingRef="HP">
        <MedGen CUI="C0029124" Name="Optic atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1359162" TraitType="Disease" MappingType="XRef" MappingValue="165500" MappingRef="OMIM">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538669" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008499" MappingRef="HP">
        <MedGen CUI="C1855925" Name="Hyperopia, high" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000540" MappingRef="HP">
        <MedGen CUI="C0020490" Name="Hypermetropia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41284" TraitType="Disease" MappingType="XRef" MappingValue="C0338508" MappingRef="MedGen">
        <MedGen CUI="C0338508" Name="Autosomal dominant optic atrophy classic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001156" MappingRef="HP">
        <MedGen CUI="C0221357" Name="Brachydactyly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000739" MappingRef="HP">
        <MedGen CUI="C0003467" Name="Anxiety" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5502682" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003202" MappingRef="HP">
        <MedGen CUI="C0541794" Name="Muscular atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3864653" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174109" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000504" MappingRef="HP">
        <MedGen CUI="C4025846" Name="Abnormality of vision" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1122691" TraitType="Disease" MappingType="XRef" MappingValue="C0751651" MappingRef="MedGen">
        <MedGen CUI="C0751651" Name="Mitochondrial disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7527458" TraitType="Finding" MappingType="Name" MappingValue="limited range of motion of upper ankle" MappingRef="Preferred">
        <MedGen CUI="None" Name="limited range of motion of upper ankle" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2016-08-24">SCV000071624</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

